Picture1.png
IMG_5729
IMG_5729

press to zoom
IMG_5702_edited
IMG_5702_edited

press to zoom
IMG_0408_edited_edited
IMG_0408_edited_edited

press to zoom
IMG_5729
IMG_5729

press to zoom
1/6

XENOGRAFT

MODEL

CRO

DOMESTIC QUALITY at COMPETITIVE PRICES

 

When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices

SPEED TO INITIATION
 

Most efficacy studies can be initiated within two business days.

PERSONAL TOUCH

 

We love our clients!  We take a personal interest in our clients and their studies.  

Xenografts models entail the implantation of human cancer cells into a host animal, typically an immunocompromised mouse or rat.  Xenograft tumor models are effective tools for assessing in vivo efficacy of candidate cancer drugs.   
Our services include custom xenograft tumor models, fluorescent imaging, MTD studies, pre-clinical drug formulation, tumor collection, organ collection, histology, and pharmacodynamic studies (ELISA, Luminex, PCR, sequencing).  Please see below for our available models or to request a quote.  

XENOGRAFT MODELS

(CELL LINES)

Brain
SF295
U87 MG

 
Breast
HCC1954
JIMT-1
MDA-MB-231
MDA-MB-468
SK-BR-3

Colon
COLO-205
DLD-1
HCT116
HT-29
RKO
SW480
SW-620

Gastric (Stomach)
AGS
NCI-N87
SNU-16
 
Leukemia & Lymphoma 
DOHH2
HL-60
K-562
MOLM-13
MV4-11
OCI-AML-3
Raji
Ramos
SKM-1

*Other cell lines are possible, please contact us about your cell line of choice

QUOTE REQUEST FORM

xenograft studies

Please fill out the form below

We will respond with a quote within one business day

Route of Administration?
Other options:
Is the planned study part of a grant application?
Liver
Hep3B
HepG2
Huh-7

Lung
A549
H460
H1703
H1975

Melanoma (Skin)
A375
 
Ovarian
OV-CAR3
SKOV-3

Pancreatic
AsPC-1
BxPc-3
MIAPaCa-2
PANC-1
 
Prostate
DU-145
LNCaP
PC-3
VcAP

Renal (Kidney)
786-O
A498
Caki-1

Sarcoma
A673
SK-ES-1
SK-N-MC

MEET OUR SCIENTIFIC DIRECTOR

Bret Stephens, PhD
  • LinkedIn Social Icon

Dr. Stephens has a broad in vivo biology background that comes from twenty years of involvement in cancer drug discovery in both academic and pharmaceutical industry settings.

 

Dr. Stephens received his PhD in Molecular Biology from the University of Arizona.

 

Previous to joining Rincon Bio, Dr. Stephens worked at Tolero Pharmaceuticals, Huntsman Cancer Institute (University of Utah), and the BioDesign Institute (Arizona State University), where he focused on cancer small molecule drug development.

ABOUT US

Founded in 2013, Rincon Bio is a pre-clinical CRO focusing on in vivo cancer efficacy studies, both allogeneic (human cell models) and syngeneic (immunotherapy models).

 

The staff at Rincon Bio have performed hundreds of efficacy studies for pharmaceutical researchers across the United States and Europe, both in industry and in academia. We've worked in the world of small, agile, start-up pharma, which gives us a unique perspective as a CRO.  We appreciate that your priorities change quickly, and you need a partner that can adapt along with you.  Furthermore, we can initiate most efficacy studies more quickly than any other CRO. 

 

We understand the importance of transparency and communication: at Rincon Bio, our clients are assigned a single point-of-contact, who is responsible for managing their study from conception to completion. 

Rincon Bio is a US-based organization, born from a desire to simplify the process of running cancer efficacy studies, and to provide domestic quality at competitive prices. We are The Cancer Model CRO - we believe in doing one thing, and doing it well.  

 

If you do decide to run your study at Rincon Bio, the process will be easy, streamlined, and pleasant.  

 

Email: info@rinconbio.com
Tel:  760-713-6613

Utah: 

5201 S. Green St, Suite 160

Salt Lake City, UT 84123

California: 

3156 Vista Way, Suite 220

Oceanside, CA 92056

 

CONTACT US